Carl June
Director, Center for Cellular Immunotherapies · University of Pennsylvania Health System
Credentials: · · ·
History
PresentCenter for Cellular Immunotherapies · University of Pennsylvania Health System
- Present
Parker Institute for Cancer Therapy Center · University of Pennsylvania Health System
- Present
Parker Institute for Cancer Immunotherapy at the University of Pennsylvania Center · University of Pennsylvania Health System
- 1983–1985
University of Washington and Fred Hutchinson Cancer Research Center
- 1975–1979
- 1978–1979
World Health Organization Immunology Research and Training Center
Research
Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
New England Journal of Medicine · 2018 · 4,577 citations
Chimeric antigen receptor T cells for sustained remissions in leukemia
New England Journal of Medicine · 2014 · 4,445 citations
Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia
Case report · New England Journal of Medicine · 2011 · Last of 5 authors · 2,911 citations
59 papers
54 papers
36 papers · 4 as a fellow
36 papers · 6 as a fellow
35 papers
35 papers · 21 as a resident
35 papers · 5 as a fellow
33 papers
Grants
- 2026–2031
Precision UCART and Nanoparticle Combination to Combat Hostile Microenvironments (PUNCH)
National Cancer Institute · R01
Contact PI · $673K · University of Pennsylvania
- 2017–2028
Enhancing Chimeric Antigen Receptor T Cell Therapies for HematologicMalignancies: Beyond CART 19
National Cancer Institute · P01
Contact PI · $24.1M · University of Pennsylvania
- 2025–2028
Next Generation T Cell Therapies for Mutant KRAS Solid Tumors
National Cancer Institute · UH3
PI · $4.6M · University of Pennsylvania
- 2021–2028
National Institute of Allergy and Infectious Diseases · U01
PI · $19.2M · University of Pennsylvania
Clinical trials
- 2014–2021
Study chair · Completed · Phase 1
University of Pennsylvania
- 2006–2017
Study chair · Completed · Phase 1
University of Pennsylvania